Testing preexisting antibodies prior to AAV gene transfer therapy: rationale, lessons and future considerations
2022 · Molecular Therapy — Methods & Clinical Development · 102 citations
https://doi.org/10.1016/j.omtm.2022.02.011
S
Sohrab Khan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
756
Citations
13
h-index
15
i10-index
Sohrab Khan is an academic researcher from Sarepta Therapeutics (United States). The author has contributed to research in topics: HIV Research and Treatment & Herpesvirus Infections and Treatments & Immune Cell Function and Interaction. The author has an h-index of 13, co-authored 19 publications.
ORCID: 0000-0002-9564-5092Papers by this author
worksMeasuring Glutathione Redox Potential of HIV-1-infected Macrophages
2014 · Journal of Biological Chemistry · 65 citations
https://doi.org/10.1074/jbc.m114.588913
Apoptosis-induced activation of HIV-1 in latently infected cell lines
2015 · Retrovirology · 45 citations
https://doi.org/10.1186/s12977-015-0169-1
Immunologic investigations into transgene directed immune-mediated myositis following delandistrogene moxeparvovec gene therapy
2025 · Scientific Reports · 20 citations
https://doi.org/10.1038/s41598-024-84077-w
Identification of proteins responding to pathogen-infection in the red alga Pyropia yezoensis using iTRAQ quantitative proteomics
2018 · BMC Genomics · 18 citations
https://doi.org/10.1186/s12864-018-5229-1
Cyclin K Inhibits HIV-1 Gene Expression and Replication by Interfering with Cyclin-dependent Kinase 9 (CDK9)-Cyclin T1 Interaction in Nef-dependent Manner
2011 · Journal of Biological Chemistry · 17 citations
https://doi.org/10.1074/jbc.m110.201194
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat